Identificación de la actividad antimicrobiana de infusiones de manzanilla en Staphyloccocus Aureus y Escherichia Coli
Cargando...
Fecha
2024
Autores
Ospino Espinosa, Veronica Patricia
Martínez Fonseca, Nohelys
Meza Urda, Kiara Marcela
Título de la revista
ISSN de la revista
Título del volumen
Editor
Ediciones Universidad Simón Bolívar
Facultad de Ciencias Básicas y Biomédicas
Facultad de Ciencias Básicas y Biomédicas
Resumen
La Organización Mundial de la salud ha presentado la necesidad de integrar los sistemas de
salud tradicionales con el sistema de salud estatal, esto plantea un reto en la validación de los
diferentes tipos de tratamientos que han sido utilizados por las comunidades de manera
ancestral. Es así, como el propósito de este estudio es identificar la acción antimicrobiana de
Matricaria Chamomilla L conocida como manzanilla, descrita en la literatura por su amplio
efecto terapéutico en enfermedades infecciosas e inflamatorias; el método usado para este fin
fue un estudio observacional para identificar la Concentración Inhibitoria Mínima de las
flores de la planta frente a Staphylococcus aureus y Escherichia Coli, Según los criterios de
National Reference System for the Clinical Laboratory. Los resultados del estudio indican
que las infusiones de manzanilla poseen compuestos activos capaces de inhibir el crecimiento
de Staphylococcus aureus y Escherichia Coli, existe un efecto de inhibición dependiendo del
origen geográfico de la planta. Las principales conclusiones muestran el potencial terapéutico
de la manzanilla en el tratamiento de infecciones bacterianas, lo cual justifica el uso que
tradicionalmente se ha dado a la manzanilla en el tratamiento de enfermedades de origen
infeccioso sobre todo a nivel intestinal, las principales limitaciones se encuentran en la
extracción de los componentes de la planta y este hecho impulsa la continuidad de futuros
estudios que ayuden a la identificación precisa de estos.
The World Health Organization has presented the need to integrate traditional health systems with the state health system, this poses a challenge in the validation of the different types of treatments that have been used by communities in an ancestral way. Thus, the purpose of this study is to identify the antimicrobial action of Matricaria Chamomilla L known as chamomile, described in the literature for its broad therapeutic effect in infectious and inflammatory diseases; The method used for this purpose was an observational study to identify the Minimum Inhibitory Concentration of the flowers of the plant against Staphylococcus aureus and Escherichia coli, according to the criteria of the National Reference System for the Clinical Laboratory. The results of the study indicate that chamomile infusions have active compounds capable of inhibiting the growth of Staphylococcus aureus and Escherichia coli. There is an inhibition effect depending on the geographical origin of the plant. The main conclusions show the therapeutic potential of chamomile in the treatment of bacterial infections, which justifies the traditional use of chamomile in the treatment of diseases of infectious origin, especially at the intestinal level. The main limitations are found in the extraction of the components of the plant and this fact encourages the continuity of future studies that help in the precise identification of these.
The World Health Organization has presented the need to integrate traditional health systems with the state health system, this poses a challenge in the validation of the different types of treatments that have been used by communities in an ancestral way. Thus, the purpose of this study is to identify the antimicrobial action of Matricaria Chamomilla L known as chamomile, described in the literature for its broad therapeutic effect in infectious and inflammatory diseases; The method used for this purpose was an observational study to identify the Minimum Inhibitory Concentration of the flowers of the plant against Staphylococcus aureus and Escherichia coli, according to the criteria of the National Reference System for the Clinical Laboratory. The results of the study indicate that chamomile infusions have active compounds capable of inhibiting the growth of Staphylococcus aureus and Escherichia coli. There is an inhibition effect depending on the geographical origin of the plant. The main conclusions show the therapeutic potential of chamomile in the treatment of bacterial infections, which justifies the traditional use of chamomile in the treatment of diseases of infectious origin, especially at the intestinal level. The main limitations are found in the extraction of the components of the plant and this fact encourages the continuity of future studies that help in the precise identification of these.
Descripción
Palabras clave
Matricaria Chamomilla L, Concentración mínima inhibitoria, Antimicrobianos
